Pancreatic Ductal Adenocarcinoma — Trials

Pancreatic Ductal Adenocarcinoma — Trials · CancerIndex

Clinical trials

Registered studies

414 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 208
Recruiting: 129
Ph III recruiting: 13
Growth YoY: +56.5%
Industry share: 50%
Top sponsor: Revolution Medicines, Inc.
Termination share: 46.8%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (56)

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03012282	CT Perfusion Images in Assessing Treatment Response in Patients With Pancreatic Cancer	terminated	N/A	70	University of WashingtonOTHER	1	Jul 6, 2022	clinicaltrials
NCT03852836	Evaluation of MRI Sequences for Ultra-rapid Acquisition of Bile Ducts Images(BiliFast)	terminated	N/A	53	IHU StrasbourgOTHER	1	Apr 6, 2022	clinicaltrials